Gabriel Belfort

Gabriel Belfort possesses extensive expertise in clinical development and operations, particularly within the central nervous system therapeutic area. As Senior Vice President and Bemdaneprocel Product Lead at BlueRock Therapeutics, Gabriel was responsible for the clinical and commercial success of a product. Previous roles include Vice President of Clinical Development at Axial Therapeutics and Vice President of Clinical Development Sciences and Operations at Praxis Precision Medicines, where 14 clinical trials were designed and analyzed across various neurological disorders. Gabriel's experience also encompasses a Senior Medical Director position at Takeda, focusing on transitioning early-stage therapeutic assets to later development stages, and substantial contributions as a Senior Scientist at SAGE Therapeutics, involving drug discovery and translational neuroscience. Gabriel holds an MD/PhD from Boston University School of Medicine and a Bachelor of Science in Biochemistry from Middlebury College.